Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting Prostate Cancer Survival

BACKGROUND: Nearly half of patients with prostate cancer will develop metastasis. Immunotherapy is currently a promising strategy for treating metastatic prostate cancer. This study aimed to construct an immune subtyping system and provide a more comprehensive understanding of tumor microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Nan, Yu, Kai, Lin, Zhong, Zeng, Dingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866019/
https://www.ncbi.nlm.nih.gov/pubmed/35222640
http://dx.doi.org/10.1155/2022/1183173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866019/
https://www.ncbi.nlm.nih.gov/pubmed/35222640
http://dx.doi.org/10.1155/2022/1183173

Ejemplares similares